Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · Mitragynine

Mitragynine in Tonga: not individually verified

Not individually verified

We have not confirmed that Mitragynine specifically is scheduled in Tonga, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.

What is on record
Not confirmed. Mitragynine is kratom's principal alkaloid, checked here as its own molecule distinct from the finding for kratom leaf in this country. 'Mitragynine' and 'Mitragyna speciosa alkaloid' were searched against Schedule 1 of the Illicit Drugs Control Act, pages 21 to 23, and against Schedule 2's controlled chemicals list, and neither names it. Mitragynine's corynanthe-type indole alkaloid skeleton, a tetracyclic structure built around an indole ring fused to a quinolizidine system, shares no ring type, functional group or side-chain relationship with any opioid, phenethylamine, benzodiazepine, barbiturate or cannabinoid named in Schedule 1, so no isomer, homologue or hydrogenation relationship for the 2020 analogue clause to use could be identified, despite mitragynine's opioid-receptor activity being pharmacologically similar in effect to several named opioids.

Confirm directly with Tonga’s national drug authority or your own embassy before you rely on anything.

This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.